Kiniksa Pharmaceuticals International Asset Turnover Growth & History (KNSA)
Kiniksa Pharmaceuticals International's asset turnover was 1.01 for fiscal 2025.
View full Kiniksa Pharmaceuticals International company overviewKiniksa Pharmaceuticals International annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.01 | 0.24 | +31.83% |
| 2024 | 2024-12-31 | 0.76 | 0.22 | +39.50% |
| 2023 | 2023-12-31 | 0.55 | −0.09 | −13.80% |
| 2022 | 2022-12-31 | 0.64 | 0.50 | +380.33% |
| 2021 | 2021-12-31 | 0.13 | — | — |
Kiniksa Pharmaceuticals International quarterly asset turnover
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.08 | 0.20 | +22.77% |
| Q1 2026 | 2026-03-31 | 1.06 | 0.20 | +23.09% |
| Q4 2025 | 2025-12-31 | 1.01 | 0.24 | +31.83% |
| Q3 2025 | 2025-09-30 | 0.94 | 0.20 | +27.52% |
| Q2 2025 | 2025-06-30 | 0.88 | 0.22 | +33.23% |
| Q1 2025 | 2025-03-31 | 0.86 | 0.23 | +37.15% |
| Q4 2024 | 2024-12-31 | 0.76 | 0.22 | +39.50% |
| Q3 2024 | 2024-09-30 | 0.74 | 0.21 | +40.23% |
| Q2 2024 | 2024-06-30 | 0.66 | −0.15 | −18.32% |
| Q1 2024 | 2024-03-31 | 0.63 | −0.07 | −10.61% |
| Q4 2023 | 2023-12-31 | 0.55 | −0.09 | −13.80% |
| Q3 2023 | 2023-09-30 | 0.53 | — | — |
| Q2 2023 | 2023-06-30 | 0.81 | — | — |
| Q1 2023 | 2023-03-31 | 0.70 | — | — |
| Q4 2022 | 2022-12-31 | 0.64 | — | — |
Kiniksa Pharmaceuticals International asset turnover trends
Between the periods ended 2021-12-31 and 2025-12-31, Kiniksa Pharmaceuticals International's asset turnover increased from 0.13 to 1.01, a change of 0.88. The latest reported quarter, Q2 2026, shows 1.08.
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kiniksa Pharmaceuticals International source filings ↗